Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
Vale ECSD, Garcia LC.
An Bras Dermatol. 2023 May-Jun;98(3):355-372. doi: 10.1016/j.abd.2022.09.005. Epub 2023 Mar 1.
Cutaneous lupus erythematosus in dogs: a comprehensive review.
Olivry T, Linder KE, Banovic F.
BMC Vet Res. 2018 Apr 18;14(1):132. doi: 10.1186/s12917-018-1446-8.
Cutaneous Lupus Erythematosus: Progress and Challenges.
Petty AJ, Floyd L, Henderson C, Nicholas MW.
Curr Allergy Asthma Rep. 2020 Apr 4;20(5):12. doi: 10.1007/s11882-020-00906-8.
Cutaneous lupus erythematosus - from pathogenesis to targeted therapy.
Klein B, Billi AC, Abernathy-Close L, Kahlenberg JM.
Nat Rev Rheumatol. 2025 Dec;21(12):703-718. doi: 10.1038/s41584-025-01318-6. Epub 2025 Nov 7.
Lupus erythematosus: Management of cutaneous manifestations during pregnancy.
Vieitez Frade J, Filipe P.
Dermatol Ther. 2022 Jun;35(6):e15486. doi: 10.1111/dth.15486. Epub 2022 Apr 29.
A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus.
Curtiss P, Walker AM, Chong BF.
Front Immunol. 2022 Mar 11;13:866319. doi: 10.3389/fimmu.2022.866319. eCollection 2022.
Cutaneous lupus erythematosus.
Tull TJ, Pink AE, Benton EC, D'Cruz D.
Br J Hosp Med (Lond). 2015 Nov;76(11):C162-5. doi: 10.12968/hmed.2015.76.11.C162.
Cutaneous lupus erythematosus induced by drugs - novel insights.
Borucki R, Werth VP.
Expert Rev Clin Pharmacol. 2020 Jan;13(1):35-42. doi: 10.1080/17512433.2020.1698290. Epub 2019 Dec 2.
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Little AJ, Vesely MD.
Yale J Biol Med. 2020 Mar 27;93(1):81-95. eCollection 2020 Mar.
Role of neutrophils in cutaneous lupus erythematosus.
Yamamoto T.
J Dermatol. 2024 Feb;51(2):180-184. doi: 10.1111/1346-8138.17036. Epub 2023 Nov 27.
